Sientra Inc (SIENQ)

[CHA-RU]

Sientra up 40% premarket on looming return to market of Silimed implants

Jan. 8, 2016 8:39 AM • SA Editor Douglas W. House

Micro cap Sientra (NASDAQ:SIEN) is up 40% premarket on increased volume in response to a published letter to doctors from Chairman & CEO Jeff Nugent saying that the company has submitted all of the third testing data of its products to the FDA. He says that, in the company's opinion, the results show that all are safe and present no significant risk to patients. If the FDA agrees, then their implants will be back on the market.The company instituted a voluntary hold on implant sales in October after quality issues surfaced at Brazil-based Silimed.Previously: Sientra's silicon implant supplier in Brazil shut down by regulators; shares slump 24% premarket (Oct. 5, 2015)